Abstract
Epidermolysis bullosa (EB) is a rare heterogeneous genetic mechanobullous skin disorder that is characterized by increased skin fragility leading to blistering following minor trauma. EB may be inherited as an autosomal dominant or an autosomal recessive disorder and can be classified into dystrophic EB (DEB), junctional EB (JEB), and EB simplex (EBS). A total of 28 Saudi patients with EB were included in this observational, retrospective chart-review study. A consecutive non-probability sampling technique was used to approach all affected patients. Molecular analysis was done to test the patients’ genomic DNA using a custom-designed AmpliSeq panel of suspected genes. All disease-causing variants were checked against available public databases. Twelve patients (42.9%) were found to have DEB, 6 patients (21.4%) with JEB, and 10 patients (35.7%) with EBS. The molecular genetic results revealed detections of 24 various homozygous genetic variations in the genes associated with EB, of which 14 were novel mutations. The most frequent variations were detected in COL7A1 in 12 cases (42.9%), followed by LAMB3 in 5 cases (17.9%), TGM5 in 4 cases (14.3%), and other genes. Furthermore, the majority (87.5%) of EB cases were confirmed to have homozygous mutations, and few were documented with positive consanguinity history. Only 3 cases (12.5%) were found to be autosomal dominant displaying heterozygous mutations. This is the first study to establish the EB genetic profile in Saudi Arabia where DEB is the most frequent type. A total of 14 novel mutations were identified that had not been previously reported. Consanguineous marriage is clearly recognized in the Saudi population; therefore, we propose a nationwide EB program that would help extend the spectrum of the genetic profile and help in the diagnosis and better understanding of this disease.
Highlights
Inherited epidermolysis bullosa (EB) is a heterogeneous group of skin disorders characterized by increased skin fragility leading to blister formation following minor trauma (Fine 2010; Mariath et al, 2020)
The enrolled patients were diagnosed with Epidermolysis bullosa (EB) and skin fragility disorders in the period between 1998 and 2020 and treated at the same center under the divisions of dermatology, general pediatrics, ophthalmology, and dentistry
The mutations were detected in 7 genes: COL7A1, LAMB3, TGM5, PLEC, DST, KRT14, and COL17A1
Summary
Inherited epidermolysis bullosa (EB) is a heterogeneous group of skin disorders characterized by increased skin fragility leading to blister formation following minor trauma (Fine 2010; Mariath et al, 2020). EB may be inherited as either autosomal dominant or autosomal recessive This disorder is caused so far by more than 29 gene mutations encoding structural proteins within the skin with functional absence or loss that leads to instability of the micro-architectural connections between the dermis and epidermis, leading to blister formation (Has et al, 2020; Mariath et al, 2020). Kindler syndrome is a rare type of EB caused by mutations in the FERMT1 gene and is inherited in an autosomal recessive pattern. Dystrophic EB is caused by mutations in the gene encoding type VII collagen leading to the separation of the sub-basal lamina. Junctional EB results from mutations in genes encoding either laminin-332 or collagen type XVII, resulting in blister formation within the lamina lucida of the basement membrane. EBS is usually inherited in an autosomal dominant pattern, but in rare cases, it is inherited as autosomal recessive
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.